Publications

Introduction

The College offers the following publications to its members, please visit the digital library to view these publications.

• Neuropsychopharmacology is an international scientific journal and the official publication of the ACNP. Published monthly, it is under the direction of Co-Principal Editors Lisa Monteggia, Ph.D. & Tony P. George, M.D., FRCPC.
• Neuropsychopharmacology Reviews is published annually as the 1st issue of Neuropsychopharmacology. The Co-Deputy Editors are Carolyn Rodriguez, M.D., Ph.D. and Charles Zorumski, M.D. The series editors are Deanna Barch, Ph.D. and Conor Liston, M.D., Ph.D.
• NPP-Digital Psychiatry and Neuroscience is an Open-Access journal covering research that involves the use of digital technologies. DPN is an official publication of ACNP and is published online-only under the direction of Principal Editor, William A. Carlezon, Jr., Ph.D.
• ACNP Bulletin is published quarterly and keeps the college apprised of recent events, updates on future events, and timely member focuses.
• Psychopharmacology: The Fourth Generation of Progress an archival, citable publication revealing the depth of development and progress in the field of neuropsychopharmacology.
• Neuropsychopharmacology: The Fifth Generation of Progress an archival, citable publication revealing the continued evolution of development and progress in the field of neuropsychopharmacology.

NEATOR Award

The Neuropsychopharmacology Editors’ Award for a Transformative Original Report (also known as the NEATOR) was established in 2013 and is intended to recognize the “top” original report published in print in Neuropsychopharmacology during the previous calendar year. 

2023: Friederike Holze and Matthias E. Liechti – Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology (2022) 47: 1180-1187

2022: Abhishek Jaywant and Faith Gunning – Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology (2021) 46: 2235-2240

2021: Chadi G. Abdallah – Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology (2020) 45: 990–997

2020: Samuel W. Centanni & Danny G. Winder – Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence. Neuropsychopharmacology (2019) 4 44: 526–537

2019: Ziva Cooper – Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology (2018) 43: 2046-2055

2018: Susanne Vogel – Stress Induces a Shift Towards Striatum-Dependent Stimulus-Response
Learning via the Mineralocorticoid Receptor. Neuropsychopharmacology (2017) 42: 1262

2017: Katie McLaughlin – Maltreatment Exposure, Brain Structure, and Fear Conditioning in Children and Adolescents. Neuropsychopharmacology (2016) 41: 1956

2016: Naomi Eisenberger –Sex Differences in Depressive and Socioemotional Responses to an Inflammatory Challenge: Implications for Sex Differences in Depression. Neuropsychopharmacology (2015) 40: 1709

2015: Rainer Spanagel – Acamprosate Produces Its Anti-Relapse Effects Via Calcium. Neuropsychopharmacology (2014) 39: 783

2014: Carolyn Rodriguez – Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept. Neuropsychopharmacology (2013) 38: 2475

2013: Michael Baumann – The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 1192

NEAR Award

The Neuropsychopharmacology Editors’ Award for a Review (also known as the NEAR) was established in 2017 and is intended to recognize the “top” review paper published in print in Neuropsychopharmacology during the previous calendar year. 

2023: Diego A. Pizzagalli and Angela Roberts – Prefrontal cortex and depression. Neuropsychopharmacology (2022) 47: 225–246

2022: Markus Heilig – Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology (2021) 46: 1715–1723

2021: Lee Hogarth – Addiction is driven by excessive goal-directed drug choice under negative affect: translational critique of habit and compulsion theory. Neuropsychopharmacology (2020) 45: 720–735

2020: Jill B. Becker & Elena Chartoff – Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology (2019) 44: 166–183

2019: Deborah Hasin – US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology (2018) 43: 195-212

2018: Timothy Dinan –  Microbes, Immunity, and Behavior: Psychoneuroimmunology
Meets the Microbiome. Neuropsychopharmacology Reviews (2017) 42: 178

2017: Bruce McEwen –  Stress Effects on Neuronal Structure: Hippocampus, Amygdala and Prefrontal Cortex. Neuropsychopharmacology Reviews (2016) 41: 3

NEECA Award

The Neuropsychopharmacology Editors’ Early Career Award (also known as the NEECA) was established in 2019 and is intended to provide targeted support to new PIs, operating in their own independent labs, consistent with the ACNP’s career development-related mission.  This award will be given for an NPP original report (non-review) published in print in the previous calendar year. 

2023: Anna Konova – A neuroeconomic signature of opioid craving: How fluctuations in craving bias drug-related and nondrug-related value. Neuropsychopharmacology (2022) 47: 1440-1448

2022: Nicole Crowley – Somatostatin neurons control an alcohol binge drinking prelimbic microcircuit in mice. Neuropsychopharmacology (2021) 46: 1906–1917

2021: Zoe Donaldson – Optogenetic reactivation of prefrontal social neural ensembles mimics social buffering of fear. Neuropsychopharmacology (2020) 45: 1068–1077

2020: Erin Calipari – Cues play a critical role in estrous cycle‐dependent enhancement of cocaine reinforcement. Neuropsychopharmacology (2019) 44: 1189–1197

2019: Anna Taylor – The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence. Neuropsychopharmacology  (2018) 43: 2606-2614